Non-survivors (n = 122) | Survivors (n = 42) | Crude odds ratio | 95% confidence interval | |
---|---|---|---|---|
Beta-lactam antibiotics | ||||
Penicillin | 65 (53.3) | 21 (50.0) | 1.140 | 0.565–2.300 |
Cephem | 60 (49.2) | 21 (50.0) | 0.968 | 0.480–1.951 |
Carbapenem | 99 (81.1) | 30 (71.4) | 1.722 | 0.767–3.865 |
Macrolide | 41 (33.6) | 25 (59.5) | 0.344 | 0.167–0.708 |
Fluoroquinolone | 68 (55.7) | 21 (50.0) | 1.259 | 0.624–2.542 |
Tetracycline | 18 (14.8) | 5 (11.9) | 1.281 | 0.444–3.695 |
Trimethoprim-sulfamethoxazole | 78 (63.9) | 31 (73.8) | 0.629 | 0.288–1.373 |
Anti-MRSA drugs | 83 (68.0) | 24 (57.1) | 1.596 | 0.777–3.279 |
Anti- influenza drugs | 10 (8.2) | 9 (21.4) | 0.327 | 0.123–0.873 |
Anti-cytomegalovirus drugs | 29 (23.8) | 8 (19.0) | 1.325 | 0.552–3.182 |
Anti-fungal drugs | 64 (52.5) | 13 (31.0) | 2.462 | 1.169–5.182 |
Low-dose Steroid | 116 (95.1) | 41 (97.6) | 0.472 | 0.055–4.035 |
High-dose Steroid | 105 (86.1) | 33 (78.6) | 1.684 | 0.686–4.133 |
High-dose cyclophosphamide | 38 (31.1) | 6 (14.3) | 2.714 | 1.055–6.986 |
Other immunosuppressant | 42 (34.4) | 8 (19.0) | 2.231 | 0.948–5.251 |
Protease inhibitor | 66 (54.1) | 14 (33.3) | 2.357 | 1.132–4.910 |
Recombinant human soluble thrombomodulin | 43 (35.2) | 12 (28.6) | 1.361 | 0.633–2.926 |
Sivelestat sodium | 64 (52.5) | 18 (42.9) | 1.471 | 0.726–2.983 |
Duration of ECMO, day | 14 (7.8–27.3) | 7.5 (4.0–14.3) | 1.043 | 1.010–1.077 |
Duration of ventilation, day | 20.0 (14.0–36.5) | 13.5 (6.8–32.8) | 1.012 | 0.991–1.033 |
CHDF | 79 (64.8) | 16 (38.1) | 2.985 | 1.446–6.165 |